Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Coronavirus genomic RNA packaging.

Masters PS.

Virology. 2019 Aug 30;537:198-207. doi: 10.1016/j.virol.2019.08.031. [Epub ahead of print] Review.

PMID:
31505321
2.

A key role for the carboxy-terminal tail of the murine coronavirus nucleocapsid protein in coordination of genome packaging.

Kuo L, Koetzner CA, Masters PS.

Virology. 2016 Jul;494:100-7. doi: 10.1016/j.virol.2016.04.009. Epub 2016 Apr 19.

3.

Analyses of Coronavirus Assembly Interactions with Interspecies Membrane and Nucleocapsid Protein Chimeras.

Kuo L, Hurst-Hess KR, Koetzner CA, Masters PS.

J Virol. 2016 Apr 14;90(9):4357-4368. doi: 10.1128/JVI.03212-15. Print 2016 May.

4.

Dissection of amino-terminal functional domains of murine coronavirus nonstructural protein 3.

Hurst-Hess KR, Kuo L, Masters PS.

J Virol. 2015 Jun;89(11):6033-47. doi: 10.1128/JVI.00197-15. Epub 2015 Mar 25.

5.

Recognition of the murine coronavirus genomic RNA packaging signal depends on the second RNA-binding domain of the nucleocapsid protein.

Kuo L, Koetzner CA, Hurst KR, Masters PS.

J Virol. 2014 Apr;88(8):4451-65. doi: 10.1128/JVI.03866-13. Epub 2014 Feb 5.

6.
7.

Negatively charged residues in the endodomain are critical for specific assembly of spike protein into murine coronavirus.

Yao Q, Masters PS, Ye R.

Virology. 2013 Jul 20;442(1):74-81. doi: 10.1016/j.virol.2013.04.001. Epub 2013 Apr 28.

8.

Functional analysis of the murine coronavirus genomic RNA packaging signal.

Kuo L, Masters PS.

J Virol. 2013 May;87(9):5182-92. doi: 10.1128/JVI.00100-13. Epub 2013 Feb 28.

9.

Evolved variants of the membrane protein can partially replace the envelope protein in murine coronavirus assembly.

Kuo L, Masters PS.

J Virol. 2010 Dec;84(24):12872-85. doi: 10.1128/JVI.01850-10. Epub 2010 Oct 6.

10.

The coronavirus nucleocapsid protein is dynamically associated with the replication-transcription complexes.

Verheije MH, Hagemeijer MC, Ulasli M, Reggiori F, Rottier PJ, Masters PS, de Haan CA.

J Virol. 2010 Nov;84(21):11575-9. doi: 10.1128/JVI.00569-10. Epub 2010 Aug 25.

11.

An interaction between the nucleocapsid protein and a component of the replicase-transcriptase complex is crucial for the infectivity of coronavirus genomic RNA.

Hurst KR, Ye R, Goebel SJ, Jayaraman P, Masters PS.

J Virol. 2010 Oct;84(19):10276-88. doi: 10.1128/JVI.01287-10. Epub 2010 Jul 21.

12.

Accessory protein 5a is a major antagonist of the antiviral action of interferon against murine coronavirus.

Koetzner CA, Kuo L, Goebel SJ, Dean AB, Parker MM, Masters PS.

J Virol. 2010 Aug;84(16):8262-74. doi: 10.1128/JVI.00385-10. Epub 2010 Jun 2.

13.

Identification of in vivo-interacting domains of the murine coronavirus nucleocapsid protein.

Hurst KR, Koetzner CA, Masters PS.

J Virol. 2009 Jul;83(14):7221-34. doi: 10.1128/JVI.00440-09. Epub 2009 May 6.

14.

Manipulation of the coronavirus genome using targeted RNA recombination with interspecies chimeric coronaviruses.

de Haan CA, Haijema BJ, Masters PS, Rottier PJ.

Methods Mol Biol. 2008;454:229-36. doi: 10.1007/978-1-59745-181-9_17.

PMID:
19057874
15.
16.

Isolation of avian paramyxovirus 1 from a patient with a lethal case of pneumonia.

Goebel SJ, Taylor J, Barr BC, Kiehn TE, Castro-Malaspina HR, Hedvat CV, Rush-Wilson KA, Kelly CD, Davis SW, Samsonoff WA, Hurst KR, Behr MJ, Masters PS.

J Virol. 2007 Nov;81(22):12709-14. Epub 2007 Sep 12.

17.

Exceptional flexibility in the sequence requirements for coronavirus small envelope protein function.

Kuo L, Hurst KR, Masters PS.

J Virol. 2007 Mar;81(5):2249-62. Epub 2006 Dec 20.

18.

A hypervariable region within the 3' cis-acting element of the murine coronavirus genome is nonessential for RNA synthesis but affects pathogenesis.

Goebel SJ, Miller TB, Bennett CJ, Bernard KA, Masters PS.

J Virol. 2007 Feb;81(3):1274-87. Epub 2006 Nov 8.

19.

Genetic and molecular biological analysis of protein-protein interactions in coronavirus assembly.

Masters PS, Kuo L, Ye R, Hurst KR, Koetzner CA, Hsue B.

Adv Exp Med Biol. 2006;581:163-73. Review. No abstract available.

PMID:
17037525
20.

The molecular biology of coronaviruses.

Masters PS.

Adv Virus Res. 2006;66:193-292. Review.

PMID:
16877062
21.

Triaryl pyrazoline compound inhibits flavivirus RNA replication.

Puig-Basagoiti F, Tilgner M, Forshey BM, Philpott SM, Espina NG, Wentworth DE, Goebel SJ, Masters PS, Falgout B, Ren P, Ferguson DM, Shi PY.

Antimicrob Agents Chemother. 2006 Apr;50(4):1320-9.

22.
23.

Coronavirus reverse genetics by targeted RNA recombination.

Masters PS, Rottier PJ.

Curr Top Microbiol Immunol. 2005;287:133-59. Review.

PMID:
15609511
25.

Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR.

Gillim-Ross L, Taylor J, Scholl DR, Ridenour J, Masters PS, Wentworth DE.

J Clin Microbiol. 2004 Jul;42(7):3196-206.

27.
28.

CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells.

Trifilo MJ, Montalto-Morrison C, Stiles LN, Hurst KR, Hardison JL, Manning JE, Masters PS, Lane TE.

J Virol. 2004 Jan;78(2):585-94.

29.

The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain.

de Haan CA, de Wit M, Kuo L, Montalto-Morrison C, Haagmans BL, Weiss SR, Masters PS, Rottier PJ.

Virology. 2003 Aug 1;312(2):395-406.

30.
31.

Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization.

de Haan CA, Volders H, Koetzner CA, Masters PS, Rottier PJ.

J Virol. 2002 Dec;76(24):12491-502.

32.
34.

O-glycosylation of the mouse hepatitis coronavirus membrane protein.

de Haan CA, de Wit M, Kuo L, Montalto C, Masters PS, Weiss SR, Rottier PJ.

Virus Res. 2002 Jan 30;82(1-2):77-81. Review. No abstract available.

PMID:
11887793
35.
36.
37.
38.

Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier.

Kuo L, Godeke GJ, Raamsman MJ, Masters PS, Rottier PJ.

J Virol. 2000 Feb;74(3):1393-406.

39.

Reverse genetics of the largest RNA viruses.

Masters PS.

Adv Virus Res. 1999;53:245-64. Review. No abstract available.

PMID:
10582102
40.
41.

Targeted recombination between MHV-2 and MHV-A59 to study neurotropic determinants of MHV.

Lavi E, Kuo L, Haluskey JA, Masters PS.

Adv Exp Med Biol. 1998;440:543-7.

PMID:
9782327
42.

The pathogenesis of MHV nucleocapsid gene chimeric viruses.

Lavi E, Haluskey JA, Masters PS.

Adv Exp Med Biol. 1998;440:537-41.

PMID:
9782326
43.
44.

Construction of a mouse hepatitis virus recombinant expressing a foreign gene.

Fischer F, Stegen CF, Koetzner CA, Masters PS.

Adv Exp Med Biol. 1998;440:291-5.

PMID:
9782295
45.
46.

Coronavirus particle assembly: primary structure requirements of the membrane protein.

de Haan CA, Kuo L, Masters PS, Vennema H, Rottier PJ.

J Virol. 1998 Aug;72(8):6838-50.

47.
49.

Supplemental Content

Loading ...
Support Center